Carfilzomib
Especificaciones
868540-17-4Número CAS
692-054-2Número CE
(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamideNombre IUPAC
C40H57N5O7Fórmula química
719.9 g/molPeso molecular
Carfilzomib; 868540-17-4; Kyprolis; PR-171; DTXSID4048690; NSC-758252; 72X6E3J5AR; DTXCID0028616; CHEBI:65347; N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamide; (2S)-N-((1S)-1-Benzyl-2-(((1S)-3-methyl-1-(((2R)-2-methyloxiran-2-yl)carbonyl)butyl)amino)-2-oxoethyl)-4-methyl-2-(((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)amino)pentanamide; L-Phenylalaninamide, (alphaS)-alpha-((4-morpholinylacetyl)amino)benzenebutanoyl-L-leucyl-N-((1S)-3-methyl-1-(((2R)-2-methyloxiranyl)carbonyl)butyl)-; carfilzomibum; PR171; (2S)-N-[(1S)-1-Benzyl-2-[[(1S)-3-methyl-1-[[(2R)-2-methyloxiran-2-yl]carbonyl]butyl]amino]-2-oxoethyl]-4-methyl-2-[[(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide; N-((2S)-2-((morpholin-4-ylacetyl)amino)-4-phenylbutanoyl)-L-leucyl-N-((2S)-4-methyl-1-((2R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)-L-phenylalaninamide; RefChem:57059; L01XX45; Carfilzomib (PR-171); Carfilzomib (PR171); MFCD11040997; (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide; C40H57N5O7; CHEMBL451887; (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide; NCGC00249613-01; UNII-72X6E3J5AR; Carfilzomib [USAN]; CAS-868540-17-4; (alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide; Carfilzomib [USAN:INN]; Kyprolis (TN); Carfilzomib; PR171; Carfilzomib (Standard); CARFILZOMIB [MI]; CARFILZOMIB [INN]; CARFILZOMIB [JAN]; CARFILZOMIB [VANDF]; Carfilzomib (PR-171)?; SCHEMBL85165; CARFILZOMIB [WHO-DD]; MLS006011102; Carfilzomib (JAN/USAN/INN); GTPL7420; orb1307429; CARFILZOMIB [ORANGE BOOK]; BLMPQMFVWMYDKT-NZTKNTHTSA-N; GLXC-90068; EX-A2037; ONO-7057; Tox21_113079; BDBM50277889; EBC-17178; HY-10455R; NSC756640; NSC758252; s2853; AKOS025401910; Tox21_113079_1; CCG-270405; CS-0984; CS-W004540; DB08889; FC46443; NSC 758252; NSC-756640; NCGC00249613-02; NCGC00249613-03; NCGC00249613-08; NCGC00249613-11; NCGC00249613-13; (2S)-N-[(1S)-1-benzyl-2-[[(1S)-3-methyl-1-[(2R)-2-methyloxirane-2-carbonyl]butyl]amino]-2-oxo-ethyl]-4-methyl-2-[[(2S)-2-[(2-morpholinoacetyl)amino]-4-phenyl-butanoyl]amino]pentanamide; (S)-4-Methyl-N-((S)-1-((S)-4-Methyl-1-((R)-2- Methyloxiran-2-yl)-1 -oxopentan-2-ylaMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide; AC-27051; AS-17059; BP-43632; HY-10455; SMR004660024; SY068813; NS00072616; SW218090-2; D08880; AB01565867_02; F951459; SR-01000941582; SR-01000941582-1; BRD-K15179879-001-03-2; Q15366934; (|AS)-|A-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide; (aS)-a-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalani namide; (S)-4-Methyl-N-[(S)-1-[[(S)-4-methyl-1-[(R)-2-methyloxiran-2-yl]-1-oxo-2-pentyl]amino]-1-oxo-3-phenyl-2-propyl]-2-[(S)-2-(2-morpholinoacetamido)-4-phenylbutanamido]pentanamide; L-PHENYLALANINAMIDE, (.ALPHA.S)-.ALPHA.-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-; N-{(2S)-2-[2-(Morpholin-4-yl)acetamido]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninamideSinónimos
Productos que contienen Carfilzomib
키프롤리스주30밀리그램(카르필조밉)키프롤리스주60밀리그램(카르필조밉)KYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 10 MG POLVO PARA SOLUCION PARA PERFUSIONKYPROLIS 60 mg, poudre pour solution pour perfusion
Página 1 de 4
Empresas que venden Carfilzomib
DR
Dr. Reddy's LaboratoriesIndiaFK
Fresenius Kabi Oncology LimitedIndia
ML
MSN LaboratoriesIndiaHB
Hubei Biocause Heilen Pharmaceutical Co., LtdChinaCC
Chongqing Carelife PharmaceuticalChinaHR
Hangzhou Royall Import & Export Co.,LtdChinaCL
Chainpharm LimitedChinaCS
Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaAP
Abydos PharmaChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaPágina 1 de 3